40-49 | 50-69 | Total | |
---|---|---|---|
Tumour size (mm): N = 133 | 13; 4-25 | 12; 1-35 | 13; 1-35 |
Median; range | |||
Tumour size (mm): | |||
< = 10 mm | 14 (32.6%) | 29 (32.2%) | 43 (32.3%) |
< = 15 mm | 28 (65.1%) | 63 (70.0%) | 91 (68.4%) |
11-20 mm1) | 23 (53.5%) | 42 (46.7%) | 65 (48.9%) |
> 20 mm | 6 (14.0%) | 19 (21.1%) | 25 (18.8%) |
Lymph node involvement | 8 (18.6%) | 19 (21.8%)1) | 27 (20.8%) |
Staging according to UICC | |||
I | 30 (69.8%) | 55 (61.8%) | 85 (64.4%) |
II | 13 (30.2%) | 31 (34.8%) | 44 (33.3%) |
III | 3 (3.4%) | 3 (2.3%) |